IRIS
MELONI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.211
AS - Asia 5.590
EU - Europa 5.094
SA - Sud America 732
Continente sconosciuto - Info sul continente non disponibili 208
AF - Africa 182
OC - Oceania 7
Totale 21.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.889
CN - Cina 2.586
SG - Singapore 1.311
IE - Irlanda 1.048
DE - Germania 647
HK - Hong Kong 590
BR - Brasile 575
IT - Italia 574
FI - Finlandia 569
UA - Ucraina 560
RU - Federazione Russa 525
VN - Vietnam 480
FR - Francia 313
SE - Svezia 287
GB - Regno Unito 275
CA - Canada 161
IN - India 129
ZA - Sudafrica 104
BD - Bangladesh 96
JP - Giappone 70
MX - Messico 61
IQ - Iraq 57
AR - Argentina 56
PL - Polonia 50
TR - Turchia 43
ES - Italia 41
BE - Belgio 33
NL - Olanda 33
ID - Indonesia 28
EC - Ecuador 26
AT - Austria 25
PK - Pakistan 25
CZ - Repubblica Ceca 24
SA - Arabia Saudita 20
UZ - Uzbekistan 20
MY - Malesia 19
CL - Cile 18
CO - Colombia 18
VE - Venezuela 18
CR - Costa Rica 15
PH - Filippine 15
LT - Lituania 13
MA - Marocco 13
PY - Paraguay 13
AZ - Azerbaigian 12
HN - Honduras 12
IR - Iran 12
JM - Giamaica 12
AE - Emirati Arabi Uniti 11
GT - Guatemala 11
AL - Albania 10
KE - Kenya 10
NI - Nicaragua 10
TN - Tunisia 10
CH - Svizzera 8
EG - Egitto 8
KZ - Kazakistan 8
PT - Portogallo 8
DZ - Algeria 7
EU - Europa 7
LV - Lettonia 7
NP - Nepal 7
RO - Romania 7
TT - Trinidad e Tobago 7
KR - Corea 6
MU - Mauritius 6
PA - Panama 6
PR - Porto Rico 6
RS - Serbia 6
AU - Australia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
AO - Angola 4
BG - Bulgaria 4
DK - Danimarca 4
EE - Estonia 4
HU - Ungheria 4
IL - Israele 4
JO - Giordania 4
KG - Kirghizistan 4
SN - Senegal 4
TH - Thailandia 4
BH - Bahrain 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
ET - Etiopia 3
KW - Kuwait 3
MN - Mongolia 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BS - Bahamas 2
DM - Dominica 2
GP - Guadalupe 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
Totale 20.788
Salva come PNG Salva come JPEG
Città #
Dublin 1.043
Chandler 974
San Jose 862
Ashburn 814
Singapore 733
Jacksonville 659
Dallas 623
Hong Kong 576
Council Bluffs 495
Nanjing 483
Beijing 479
Boardman 324
Los Angeles 234
Helsinki 229
Munich 229
New York 187
Princeton 182
Nanchang 178
Lauterbourg 170
Lawrence 169
Wilmington 157
Shenyang 150
Ho Chi Minh City 149
Hebei 142
Changsha 135
Medford 127
Jiaxing 126
Hanoi 113
Moscow 111
Ann Arbor 110
Milan 100
Johannesburg 92
Pavia 92
Santa Clara 92
Shanghai 92
Buffalo 81
Tianjin 81
Hangzhou 77
Turku 69
Redondo Beach 66
Tokyo 65
Orem 61
São Paulo 55
Woodbridge 49
Seattle 48
London 47
Warsaw 44
Montreal 43
Verona 42
Toronto 41
The Dalles 40
Brooklyn 39
Chicago 37
Columbus 36
Washington 35
Houston 32
Atlanta 31
Brussels 31
Denver 31
Phoenix 29
Norwalk 28
Chennai 27
San Francisco 27
Da Nang 26
Frankfurt am Main 26
Haiphong 25
Rio de Janeiro 25
Stockholm 25
Boston 23
Baghdad 22
Falkenstein 22
Zhengzhou 22
Kunming 21
Mexico City 20
Biên Hòa 18
Poplar 18
Vienna 18
Des Moines 17
Paris 17
Pune 17
Tashkent 17
Naples 16
Nuremberg 16
Manchester 15
Piscataway 15
Amsterdam 13
Belo Horizonte 13
Fairfield 13
Jinan 13
North Bergen 13
Rome 13
Guangzhou 12
Baku 11
Curitiba 11
Mumbai 11
Ninh Bình 11
Ottawa 11
Porto Alegre 11
San José 11
Taizhou 11
Totale 13.342
Salva come PNG Salva come JPEG
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 279
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 195
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 184
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 179
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 174
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 173
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 170
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 169
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 169
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 169
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 162
Fotoaferesi extracorporea nel trattamento del rigetto polmonare cronico: risultati clinici ed immunologici preliminari di una piccola coorte di pazienti sottoposti a trapianto di polmone. 161
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 161
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 159
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 159
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 159
Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients. 155
Minute pulmonary meningothelial-like nodules in the transbronchial biopsy of a lung transplant recipient 154
Specific Anti-CMV Reactivity in BAL: A Useful Tool 151
(1)H NMR To Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification. 150
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 149
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 149
Indoleamine 2,3-dioxygenase in lung allograft tolerance. 147
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 146
Regulatory T cells in kidney transplant recipients. 145
Broncho-alveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to the onset of bronchiolitis obliterans syndrome 144
Effetti clinici ed immunologici di un trattamento a lungo termine con azitromicina nella sindrome da bronchiolite obliterante dopo trapianto polmonare. 144
Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients 143
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T 142
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 142
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 141
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 141
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 140
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin 140
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 139
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 138
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 138
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 136
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 136
Aortic valve replacement performed twice through ministernotomy 15 years after lung transplantation. 135
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 135
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 134
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 134
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 133
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 130
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 130
An innovative cellular approach to BOS: targeted antibody-engineered gold nanoparticles and characterization of cells for new therapeutic treatment 130
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 130
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 130
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. 128
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 128
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 127
Incidence of de novo malignancies in lung transplant recipients in Italy: a sinle institution experience, 1991-2008. 127
Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients 127
Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation 126
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane 126
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 126
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines 126
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 125
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 123
Organ Allocation Waiting Time During Extracorporeal Bridge to Lung Transplant Affects Outcomes 121
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 120
[Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. 120
Cerebrospinal fluid ferritin in human disease. 119
Activity of Th1/Th2 lymphocytes in primary and HCV-related mesangiocapillary glomerulonephritis. 119
Human cytomegalovirus-specific CD4+ and CD8+ T-cells in organ transplant recipiets 118
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 117
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome. 117
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop 117
Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation 117
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 116
Rischio di sviluppo di tumori de-novo dopo trapianto di polmone in Italia: esperienza dell'I.R.C.C.S. Policlinico "San Matteo" di Pavia, 1991-2008. 116
Persistent human cosavirus infection in lung transplant recipient, Italy. 116
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo 115
Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients 115
Urinary monocyte chemotactic peptide (U/MCP-1) and RANTES (U/RANTES) excretion in human lupus nephritis (SLE/N) 114
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 113
Possible Disease Markers in BAL Fluid of BOS Patients 113
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 112
Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study 111
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 110
Valutazione longitudinale delle cellule treg cd4+cd25highc69- in una coorte di riceventi di trapianto polmonare (ltrs). Un'associazione con il rigetto cronico del trapianto. 110
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 108
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 108
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 108
Cytokine profile of broncho-alveolar lavage in BOOP and UIP 107
Role of interleukin18 (IL-18) and interleukin 12 (IL-12) in human lupus nephritis (SLE-N) 106
Different pathways of degradation of SP-A and saturated phosphatidylcholine by alveolar macrophages 106
Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. 106
Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients. 106
Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: A 10-year single-centre analysis 106
Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of "in vitro" culture. 105
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 105
Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus 105
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p 105
Mechanisms of lung injury in cystic fibrosis. 104
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation 104
Urinary interleukin-18 (IL-18) and monocyte chemotactic peptide-1 (MCP-1) excretion in IGA Nephropathy (IgAN) 103
Seroprevalence of hepatitis B virus markers and risk factors in patients and staff of an Italian residential institution for the mentally disabled 103
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome 103
Totale 13.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022699 0 0 0 13 22 20 20 40 50 24 117 393
2022/20232.852 297 206 15 256 290 275 1 163 1.231 21 64 33
2023/20241.302 147 210 59 79 137 341 43 79 8 101 34 64
2024/20253.149 77 210 94 109 87 231 187 282 740 113 353 666
2025/20266.993 546 417 887 732 844 360 1.351 294 604 484 232 242
2026/20271.584 163 332 402 687 0 0 0 0 0 0 0 0
Totale 21.024